| Mrs Dama Reter Yekeson-koffa, RN, SRNA | |
|
4940 Eastern Ave, Anesthesia Department Bayview Medical Center, Baltimore, MD 21224-2735 | |
| (443) 694-8960 | |
| (410) 356-5821 |
| Full Name | Mrs Dama Reter Yekeson-koffa |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 4940 Eastern Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013330851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R181175 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dama Reter Yekeson-koffa, RN, SRNA 4940 Eastern Ave, Anesthesia Department Bayview Medical Center, Baltimore, MD 21224-2735 Ph: () - | Mrs Dama Reter Yekeson-koffa, RN, SRNA 4940 Eastern Ave, Anesthesia Department Bayview Medical Center, Baltimore, MD 21224-2735 Ph: (443) 694-8960 |
News Archive
Stem cells are the ultimate mother cells of the human body. Not only do they have the capacity to self-renew, they can develop into specific cell types as the body requires. But as the human body ages, the regenerative capacity of our stem cells diminishes.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that it has submitted a Clinical Trial Authorization application to the Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 study of ALN-AAT02, an investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease.
OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche today announced that a Phase III study of Tarceva™ (erlotinib HCl), an investigational HER1/EGFR-inhibitor agent in previously treated patients with non-small cell lung cancer (NSCLC), met its primary endpoint of improving overall survival, with patients receiving Tarceva™ living longer than those in the placebo arm of the study.
Many children in inner-city schools who have long faced economic hardships also struggle with chronic health conditions that further impair their ability to learn and break free from a cycle of poverty. To address this, the H&M Conscious Foundation announced today that it is investing $1.3 million to support an innovative school-based program in New York designed to tackle health barriers that get in the way of learning for underprivileged children.
The Department of Environmental Protection today announced it is awarding nearly $2.1 million in West Nile Virus (WNV) Control Program Grants to 26 counties.
› Verified 3 days ago
Ms. Jennifer Renee Pease Moreno, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: Jhu 600 N Wolfe St, Dept Anesthesia Critical Care Medicine- Blalock 14th Fl, Baltimore, MD 21287 Phone: 410-955-4552 | |
Kristen Marll, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-601-5209 | |
Mrs. Victoria Volta Manger, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 S Caton Ave, Baltimore, MD 21229 Phone: 667-234-3045 | |
Duncan Mcelfresh, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2401 W Belvedere Ave, Anesthesia Department, Baltimore, MD 21215 Phone: 410-601-5209 Fax: 410-601-9744 | |
Mr. Michael W Hoban, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 301 Saint Paul St, Baltimore, MD 21202 Phone: 410-332-9375 | |
Kelly Mccarthy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-8667 |